In an in vivo study of mice with LCK-deficient CLL disease model, it was found that LCK-KO group mice had a significantly shorter median survival compared to wild-type healthy mice over an observation period of 350 days (47). Here, LCK is linked to B-cell chronic lymphocytic leukemia.